Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free HY Stock Alerts

Hyster-Yale (HY) Financials

Hyster-Yale logo
$35.86 -0.45 (-1.23%)
Closing price 03:59 PM Eastern
Extended Trading
$35.98 +0.11 (+0.32%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Hyster-Yale

Annual Income Statements for Hyster-Yale

This table shows Hyster-Yale's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 75 43 49 35 36 37 -173 -74 126 142 -60
Consolidated Net Income / (Loss)		 75 42 49 34 37 39 -183 -72 128 144 -58
Net Income / (Loss) Continuing Operations		 75 42 49 34 37 39 -183 -72 128 131 -100
Total Pre-Tax Income 		105 38 94 37 48 42 -155 -62 181 219 -43
Total Operating Income		 104 33 74 39 54 50 -152 -39 209 245 -22
Total Gross Profit		 431 428 503 497 542 465 363 434 786 896 633
Total Revenue		 2,578 2,570 2,885 3,179 3,292 2,812 3,076 3,548 4,118 4,308 3,769
Operating Revenue		 2,578 2,570 2,885 3,179 3,292 2,812 3,076 3,548 4,118 4,308 3,769
Total Cost of Revenue		 2,147 2,142 2,383 2,682 2,750 2,347 2,712 3,114 3,333 3,413 3,137
Operating Cost of Revenue		 2,147 2,142 2,383 2,682 2,750 2,347 2,712 3,114 3,333 3,413 3,137
Total Operating Expenses		 327 395 429 458 488 416 516 473 577 664 696
Selling, General & Admin Expense		 327 395 429 458 488 416 450 473 577 628 617
Impairment Charge		 - - - - - 0.00 66 0.00 0.00 0.00 6.80
Restructuring Charge		 - - - - - - - 0.00 0.00 36 73
Total Other Income / (Expense), net		 1.00 5.40 20 -2.20 -6.00 -7.70 -2.60 -23 -28 -26 -21
Interest Expense		 4.70 6.70 15 16 20 14 16 28 37 34 31
Interest & Investment Income		 6.10 7.10 28 10 9.30 6.60 12 11 9.80 5.50 10
Other Income / (Expense), net		 -0.40 5.00 6.30 3.80 4.50 -0.60 1.20 -5.90 -0.20 2.50 0.00
Income Tax Expense		 29 -4.00 45 2.30 11 3.70 28 9.20 53 75 15
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.40 -0.50 0.30 -0.40 0.80 1.40 -10 2.50 2.20 1.90 2.10
Basic Earnings per Share		 $4.58 $2.61 $2.95 $2.10 $2.15 $2.21 ($10.29) ($4.38) $7.35 $8.16 ($3.40)
Weighted Average Basic Shares Outstanding		 16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Diluted Earnings per Share		 $4.57 $2.61 $2.94 $2.09 $2.14 $2.21 ($10.29) ($4.38) $7.24 $8.04 ($3.40)
Weighted Average Diluted Shares Outstanding		 16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Weighted Average Basic & Diluted Shares Outstanding		 16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Cash Dividends to Common per Share		 $1.13 $1.17 $1.20 $1.23 $1.26 $1.27 $1.29 $1.29 $1.30 $1.38 $1.43

Quarterly Income Statements for Hyster-Yale

This table shows Hyster-Yale's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 38 36 25 52 63 17 10 8.60 -14 -2.30 -53
Consolidated Net Income / (Loss)		 39 36 26 52 64 18 11 8.70 -13 -1.70 -52
Net Income / (Loss) Continuing Operations		 39 36 26 52 64 18 27 9.40 -13 -2.70 -93
Total Pre-Tax Income 		51 53 42 77 90 28 24 17 -13 -4.60 -42
Total Operating Income		 59 59 49 84 96 33 32 21 -8.50 2.30 -37
Total Gross Profit		 198 204 210 236 259 193 208 178 168 156 131
Total Revenue		 1,091 1,001 1,027 1,057 1,168 1,016 1,068 910 957 979 923
Operating Revenue		 1,091 1,001 1,027 1,057 1,168 1,016 1,068 910 957 979 923
Total Cost of Revenue		 893 798 818 821 909 823 860 733 788 823 792
Operating Cost of Revenue		 893 798 818 821 909 823 860 733 788 823 792
Total Operating Expenses		 139 145 161 152 164 160 160 156 177 155 209
Selling, General & Admin Expense		 139 145 161 152 164 159 153 156 161 153 147
Restructuring Charge		 - - - 0.00 0.00 1.20 - -0.50 16 2.00 56
Total Other Income / (Expense), net		 -8.00 -6.00 -7.00 -6.90 -5.60 -5.00 -8.30 -4.50 -4.70 -6.90 -4.70
Interest Expense		 8.40 9.60 9.10 8.90 8.80 8.40 7.70 7.70 7.90 8.00 7.60
Interest & Investment Income		 3.10 2.90 2.00 1.00 2.10 3.60 -1.20 2.90 2.70 1.60 3.20
Other Income / (Expense), net		 -2.70 0.70 0.10 1.00 1.10 -0.20 0.60 0.30 0.50 -0.50 -0.30
Income Tax Expense		 12 16 16 25 26 10 13 8.10 0.20 -2.90 9.70
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.50 0.60 0.50 0.30 0.60 0.60 0.40 0.10 0.50 0.60 0.90
Basic Earnings per Share		 $2.23 $2.08 $1.48 $2.97 $3.62 $0.98 $0.59 $0.49 ($0.79) ($0.13) ($2.97)
Weighted Average Basic Shares Outstanding		 17.16M 17.18M 17.49M 17.34M 17.49M 17.50M 17.70M 17.56M 17.71M 17.72M 17.90M
Diluted Earnings per Share		 $2.21 $2.06 $1.42 $2.93 $3.58 $0.97 $0.56 $0.48 ($0.79) ($0.13) ($2.96)
Weighted Average Diluted Shares Outstanding		 17.31M 17.41M 17.49M 17.59M 17.66M 17.75M 17.70M 17.77M 17.71M 17.72M 17.90M
Weighted Average Basic & Diluted Shares Outstanding		 17.18M 17.19M 17.49M 17.50M 17.50M 17.51M 17.70M 17.71M 17.72M 17.73M 17.90M

Annual Cash Flow Statements for Hyster-Yale

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 44 -112 177 -136 -19 87 -86 -6.50 20 73 41
Net Cash From Operating Activities		 89 -49 165 68 77 167 -254 41 151 171 86
Net Cash From Continuing Operating Activities		 89 -49 165 68 77 167 -254 41 151 193 86
Net Income / (Loss) Continuing Operations		 75 42 49 34 37 39 -183 -72 128 144 -58
Consolidated Net Income / (Loss)		 75 42 49 34 37 39 -183 -72 128 144 -58
Depreciation Expense		 29 39 43 44 43 43 46 43 45 48 46
Amortization Expense		 1.20 1.10 1.40 1.70 1.90 1.70 3.10 1.40 1.40 1.50 1.40
Non-Cash Adjustments To Reconcile Net Income		 6.40 -5.40 2.90 36 34 29 43 48 61 92 65
Changes in Operating Assets and Liabilities, net		 -22 -126 69 -49 -39 55 -162 19 -84 -92 32
Net Cash From Investing Activities		 -31 -145 -47 -111 -42 -44 -25 -35 -35 -48 -63
Net Cash From Continuing Investing Activities		 -31 -145 -47 -111 -42 -44 -25 -35 -35 -43 -58
Purchase of Property, Plant & Equipment		 -47 -43 -41 -39 -50 -52 -44 -29 -35 -48 -63
Acquisitions		 - -116 -1.00 -78 - 0.00 0.00 0.00 0.00 2.20 2.60
Purchase of Investments		 0.00 0.00 -6.60 - - - 0.00 -8.40 -3.20 0.00 0.00
Sale of Property, Plant & Equipment		 14 14 1.30 5.90 7.70 8.00 4.10 1.30 1.90 1.80 2.40
Divestitures		 0.90 - - - - - 0.00 0.00 1.10 0.60 0.00
Sale and/or Maturity of Investments		 - - - - 0.00 0.00 16 0.50 1.10 0.00 0.00
Net Cash From Financing Activities		 -7.10 78 53 -88 -52 -41 194 -11 -101 -100 -0.80
Net Cash From Continuing Financing Activities		 -7.10 78 53 -88 -52 -41 194 -11 -101 -72 8.20
Repayment of Debt		 -35 -58 -192 -145 -98 -84 -70 -98 -162 -199 -173
Repurchase of Common Equity		 - - - - - - - 0.00 0.00 14 4.50
Payment of Dividends		 -18 -19 -20 -21 -21 -22 -22 -22 -24 -25 -27
Issuance of Debt		 46 156 266 78 68 65 285 109 85 138 204
Other Net Changes in Cash		 - - - - - 4.20 -1.50 -0.80 4.10 -5.20 4.00

Quarterly Cash Flow Statements for Hyster-Yale

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents		 1.10 13 0.60 -17 4.30 9.10 59 -19 -10 4.20 66
Net Cash From Operating Activities		 36 60 46 22 -2.50 70 81 -36 29 37 57
Net Cash From Continuing Operating Activities		 36 60 46 22 -2.50 70 81 -36 29 37 57
Net Income / (Loss) Continuing Operations		 39 36 26 52 64 18 11 8.70 -13 -1.70 -52
Consolidated Net Income / (Loss)		 39 36 26 52 64 18 11 8.70 -13 -1.70 -52
Depreciation Expense		 11 11 11 12 12 12 12 11 12 11 12
Amortization Expense		 0.40 0.30 0.40 0.40 0.30 0.50 0.30 0.40 0.40 0.30 0.30
Non-Cash Adjustments To Reconcile Net Income		 15 11 21 18 13 20 19 16 23 0.60 26
Changes in Operating Assets and Liabilities, net		 -30 1.70 -13 -59 -92 20 39 -72 7.50 27 70
Net Cash From Investing Activities		 -6.90 -7.90 -15 -7.00 -12 -12 -17 -10 -15 -14 -23
Net Cash From Continuing Investing Activities		 -6.90 -7.90 -18 -7.00 -12 -12 -13 -10 -15 -14 -18
Purchase of Property, Plant & Equipment		 -7.30 -8.30 -17 -7.50 -12 -10 -18 -11 -14 -15 -24
Acquisitions		 - - - 0.00 - - 4.40 0.00 -2.60 - 5.20
Sale of Property, Plant & Equipment		 0.40 0.40 0.70 0.50 0.50 0.40 0.40 0.30 1.10 0.30 0.70
Net Cash From Financing Activities		 -26 -40 -31 -31 19 -51 -38 26 -26 -18 18
Net Cash From Continuing Financing Activities		 -26 -40 -28 -31 19 -51 -9.90 26 -26 -18 27
Repayment of Debt		 -41 -41 -41 -50 -54 -53 -73 -43 -41 -42 -48
Repurchase of Common Equity		 - - 0.10 -9.10 - - 23 -4.50 0.10 -0.10 9.00
Payment of Dividends		 -6.80 -5.60 -5.60 -5.70 -7.40 -6.10 -6.10 -6.20 -7.70 -6.30 -6.50
Issuance of Debt		 21 6.50 15 34 81 8.40 46 79 22 31 72
Other Net Changes in Cash		 -1.40 0.30 1.10 -1.50 -0.60 1.80 - 1.40 2.30 -0.60 0.90

Annual Balance Sheets for Hyster-Yale

This table presents Hyster-Yale's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,096 1,287 1,648 1,742 1,847 1,860 545 2,026 2,079 2,029 2,021
Total Current Assets		 819 810 1,131 1,132 1,156 1,130 0.00 1,459 1,490 1,433 1,347
Cash & Equivalents		 155 43 220 84 65 151 - 59 79 97 123
Accounts Receivable		 324 375 453 466 468 412 - 524 498 488 490
Inventories, net		 305 352 412 534 560 509 - 800 816 754 634
Prepaid Expenses		 35 39 46 49 63 57 - 77 98 94 100
Plant, Property, & Equipment, net		 185 255 265 296 309 340 331 310 314 307 329
Total Noncurrent Assets		 93 222 251 314 383 498 214 258 275 289 345
Long-Term Investments		 43 46 82 76 80 80 - 59 57 56 58
Goodwill		 0.00 51 59 108 107 115 57 51 53 55 56
Intangible Assets		 3.60 56 56 68 60 59 51 43 39 33 32
Noncurrent Deferred & Refundable Income Taxes		 33 44 17 26 31 24 - 2.60 3.00 6.70 6.80
Other Noncurrent Operating Assets		 13 25 37 36 105 183 107 102 123 139 192
Total Liabilities & Shareholders' Equity		 1,096 1,287 1,648 1,742 1,847 1,860 1,970 2,026 2,079 2,029 2,021
Total Liabilities		 633 817 1,076 1,183 1,270 1,208 1,587 1,801 1,672 1,535 1,528
Total Current Liabilities		 505 577 692 776 817 756 0.00 1,343 1,219 1,058 1,002
Short-Term Debt		 34 129 75 91 82 83 - 286 253 199 242
Accounts Payable		 295 259 404 437 417 428 - 586 524 448 396
Current Deferred Revenue		 - - - 38 49 42 - 140 78 57 47
Current Employee Benefit Liabilities		 48 44 52 56 66 46 - 64 87 106 101
Other Current Liabilities		 - - - - - 182 - 245 270 241 211
Total Noncurrent Liabilities		 128 240 383 406 453 738 443 725 695 719 526
Long-Term Debt		 20 82 216 210 205 412 262 534 483 484 252
Asset Retirement Reserve & Litigation Obligation		 18 20 34 25 31 30 - 34 51 38 43
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 11 13 18 15 15 13 13 13 8.40 8.20
Noncurrent Employee Benefit Liabilities		 22 37 11 23 14 20 - 6.20 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 69 90 109 130 188 260 169 138 149 189 224
Redeemable Noncontrolling Interest		 - - - - - - 0.00 14 15 15 16
Total Equity & Noncontrolling Interests		 463 470 572 560 577 651 383 211 392 479 476
Total Preferred & Common Equity		 461 464 566 527 544 617 357 204 390 475 472
Total Common Equity		 461 464 565 527 544 617 46 204 390 475 472
Common Stock		 320 320 324 322 322 313 - 298 328 351 355
Retained Earnings		 337 360 389 407 427 443 249 153 256 375 289
Treasury Stock		 -43 -37 -32 -24 -16 -6.00 - - 0.00 -14 -14
Accumulated Other Comprehensive Income / (Loss)		 -154 -179 -116 -178 -189 -133 -202 -246 -194 -237 -158
Noncontrolling Interest		 1.90 6.60 6.90 32 33 34 26 6.50 2.10 4.10 4.30

Quarterly Balance Sheets for Hyster-Yale

This table presents Hyster-Yale's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets		 1,933 2,110 2,053 2,118 2,116 2,172 2,055 2,075 2,061
Total Current Assets		 1,376 1,552 1,501 1,526 1,529 1,559 1,455 1,457 1,444
Cash & Equivalents		 69 66 78 62 67 76 77 67 71
Accounts Receivable		 460 582 512 521 579 543 506 512 521
Inventories, net		 779 820 815 842 791 855 773 777 740
Prepaid Expenses		 68 84 95 101 93 86 99 101 112
Plant, Property, & Equipment, net		 302 300 299 312 311 317 313 316 321
Total Noncurrent Assets		 255 258 254 281 276 296 287 302 296
Long-Term Investments		 56 52 54 52 53 60 52 56 57
Goodwill		 49 52 51 52 52 58 51 55 56
Intangible Assets		 43 41 40 37 36 36 33 34 33
Noncurrent Deferred & Refundable Income Taxes		 4.80 2.90 2.60 3.00 2.70 2.80 6.90 7.90 8.00
Other Noncurrent Operating Assets		 103 109 106 136 133 139 144 149 143
Total Liabilities & Shareholders' Equity		 1,933 2,110 2,053 2,118 2,116 2,172 2,055 2,075 2,061
Total Liabilities		 1,798 1,804 1,733 1,689 1,634 1,623 1,526 1,512 1,505
Total Current Liabilities		 1,307 1,371 1,299 1,221 1,172 1,149 1,054 1,042 1,037
Short-Term Debt		 272 290 267 235 253 221 241 228 216
Accounts Payable		 553 577 540 566 507 528 464 465 472
Current Deferred Revenue		 153 120 99 71 66 64 52 48 44
Current Employee Benefit Liabilities		 51 59 70 52 67 83 65 78 87
Other Current Liabilities		 278 309 313 290 272 247 221 214 214
Total Noncurrent Liabilities		 490 432 433 468 462 475 472 470 468
Long-Term Debt		 273 252 243 240 249 247 243 245 252
Asset Retirement Reserve & Litigation Obligation		 32 35 42 46 36 38 41 37 38
Noncurrent Deferred & Payable Income Tax Liabilities		 11 12 12 12 12 12 9.80 10 9.20
Noncurrent Employee Benefit Liabilities		 7.90 6.00 5.90 4.70 4.60 5.10 0.00 0.00 0.00
Other Noncurrent Operating Liabilities		 167 127 131 166 161 172 179 177 168
Redeemable Noncontrolling Interest		 14 14 14 15 14 0.00 15 15 15
Total Equity & Noncontrolling Interests		 122 292 306 414 468 534 514 549 540
Total Preferred & Common Equity		 114 291 304 412 466 530 510 545 536
Total Common Equity		 114 291 304 412 466 530 510 545 536
Common Stock		 295 310 313 337 345 350 353 355 357
Retained Earnings		 151 207 237 302 359 370 377 357 348
Treasury Stock		 0.00 -0.10 0.00 -9.10 -9.10 -8.70 -17 -16 -15
Accumulated Other Comprehensive Income / (Loss)		 -332 -225 -245 -218 -230 -181 -204 -151 -153
Noncontrolling Interest		 7.50 1.80 1.80 2.30 2.20 4.10 4.30 4.20 4.30

Annual Metrics And Ratios for Hyster-Yale

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 16,323,816.00 16,390,754.00 16,462,320.00 16,560,722.00 16,666,917.00 16,805,437.00 16,826,900.00 - - - 17,733,794.00
DEI Adjusted Shares Outstanding		 16,323,816.00 16,390,754.00 16,462,320.00 16,560,722.00 16,666,917.00 16,805,437.00 16,826,900.00 - - - 17,733,794.00
DEI Earnings Per Adjusted Shares Outstanding		 4.58 2.61 2.95 2.10 2.15 2.21 -10.28 - - - -3.39
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 74 36 39 36 41 46 -107 -27 148 161 -15
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -2.66% 13.10% 17.52% -1.59%
Earnings before Interest and Taxes (EBIT)		 103 38 80 43 58 49 -151 -45 209 247 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 133 78 125 88 104 94 -102 -0.20 255 296 25
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 93 -238 70 -104 23 51 243 -345 57 143 -35
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 318 593 561 702 719 714 364 681 772 790 810
Increase / (Decrease) in Invested Capital		 -19 275 -31 141 18 -5.90 -350 318 91 19 20
Book Value per Share		 $28.22 $28.28 $34.34 $31.83 $32.66 $36.71 $2.75 $12.07 $22.69 $27.14 $26.62
Tangible Book Value per Share		 $28.00 $21.76 $27.34 $21.21 $22.65 $26.40 ($3.62) $6.52 $17.30 $22.13 $21.65
Total Capital		 516 682 863 861 864 1,146 645 1,045 1,142 935 987
Total Debt		 53 211 291 302 287 495 262 820 735 441 494
Total Long-Term Debt		 20 82 216 210 205 412 262 534 483 242 252
Net Debt		 -145 122 -11 142 142 264 262 702 600 289 313
Capital Expenditures (CapEx)		 32 29 40 33 42 44 40 28 34 46 60
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 192 319 293 363 357 306 0.00 343 445 478 464
Debt-free Net Working Capital (DFNWC)		 347 363 514 447 421 457 0.00 402 524 574 588
Net Working Capital (NWC)		 314 234 439 355 339 374 0.00 116 272 375 345
Net Nonoperating Expense (NNE)		 -0.72 -5.96 -10 2.06 4.58 7.02 77 44 20 17 43
Net Nonoperating Obligations (NNO)		 -145 122 -11 142 142 62 -19 456 365 296 318
Total Depreciation and Amortization (D&A)		 30 40 44 46 45 45 49 45 47 49 47
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $4.58 $2.61 $2.95 $2.10 $2.15 $2.21 ($10.29) ($4.38) $7.35 $8.16 ($3.40)
Adjusted Weighted Average Basic Shares Outstanding		 16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Adjusted Diluted Earnings per Share		 $4.57 $2.61 $2.94 $2.09 $2.14 $2.21 ($10.29) ($4.38) $7.24 $8.04 ($3.40)
Adjusted Weighted Average Diluted Shares Outstanding		 16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Normalized Net Operating Profit after Tax (NOPAT)		 74 23 39 36 41 46 -61 -27 148 166 40
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Hyster-Yale

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding		 - - - - - - - - 17,707,665.00 17,720,627.00 17,733,794.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 17,707,665.00 17,720,627.00 17,733,794.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - -0.79 -0.13 -2.96
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 45 41 30 56 68 21 14 11 -5.95 1.61 -26
Return On Investment Capital (ROIC_SIMPLE)		 - - 2.66% - - - 1.57% 1.10% -0.58% 0.16% -2.68%
Earnings before Interest and Taxes (EBIT)		 56 59 49 85 97 33 33 22 -8.00 1.80 -38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 68 71 61 97 109 45 45 33 4.20 13 -26
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -702 -112 -61 -740 -57 -159 -4.10 -87 -57 -9.69 -46
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 747 708 772 797 872 888 790 894 923 900 810
Increase / (Decrease) in Invested Capital		 747 152 91 797 125 180 19 98 52 11 20
Book Value per Share		 $16.93 $17.72 $22.69 $23.77 $26.62 $30.28 $27.14 $28.82 $30.76 $30.25 $26.62
Tangible Book Value per Share		 $11.48 $12.44 $17.30 $18.62 $21.62 $24.88 $22.13 $24.06 $25.72 $25.25 $21.65
Total Capital		 849 831 1,142 904 984 1,003 935 1,013 1,037 1,023 987
Total Debt		 542 511 735 475 502 469 441 484 473 468 494
Total Long-Term Debt		 252 243 483 240 249 247 242 243 245 252 252
Net Debt		 425 378 600 361 383 333 289 355 351 340 313
Capital Expenditures (CapEx)		 6.90 7.90 16 7.00 12 9.80 18 10 13 14 23
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 405 391 445 478 545 556 478 565 576 551 464
Debt-free Net Working Capital (DFNWC)		 471 469 524 540 611 632 574 642 643 622 588
Net Working Capital (NWC)		 181 202 272 305 358 411 375 401 415 407 345
Net Nonoperating Expense (NNE)		 6.11 4.15 4.31 4.65 3.98 3.17 3.70 2.33 7.45 3.31 26
Net Nonoperating Obligations (NNO)		 441 388 365 367 390 354 296 365 360 344 318
Total Depreciation and Amortization (D&A)		 12 12 12 12 13 12 12 11 12 12 12
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.23 $0.00 $1.48 $2.97 $3.62 $0.98 $0.59 $0.49 ($0.79) ($0.13) ($2.97)
Adjusted Weighted Average Basic Shares Outstanding		 17.16M 0.00 17.49M 17.34M 17.49M 17.50M 17.70M 17.56M 17.71M 17.72M 17.90M
Adjusted Diluted Earnings per Share		 $2.21 $0.00 $1.42 $2.93 $3.58 $0.97 $0.56 $0.48 ($0.79) ($0.13) ($2.96)
Adjusted Weighted Average Diluted Shares Outstanding		 17.31M 0.00 17.49M 17.59M 17.66M 17.75M 17.70M 17.77M 17.71M 17.72M 17.90M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 17.18M 0.00 17.49M 17.50M 17.50M 17.51M 17.70M 17.71M 17.72M 17.73M 17.90M
Normalized Net Operating Profit after Tax (NOPAT)		 45 41 30 56 68 21 23 11 5.04 3.01 13
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Hyster-Yale (NYSE: HY) based on quarterly results across the last four years, with a focus on how cash flow, profitability, and leverage have evolved.

  • Q4 2025: Net cash from continuing operating activities was 56,500,000, showing positive cash generation from core operations despite a quarterly net loss.
  • Q4 2025: Issuance of debt totaled 72,000,000 during the quarter, providing additional liquidity to support financing needs.
  • Q4 2025: Net cash from financing activities was 26,600,000, contributing to overall quarterly cash inflows alongside debt issuance.
  • Q1 2025: Net income attributable to common shareholders was 8,600,000, with basic and diluted earnings per share of 0.49 and 0.48 respectively, signaling a profitable quarter before later charges.
  • Revenue has trended down from about 1.016 billion in Q3 2024 to 0.923 billion in Q4 2025, indicating slower top-line growth over the period.
  • Total current liabilities around 1.037 billion (Q3 2025) versus total current assets of about 1.444 billion yields a modest current ratio near 1.39, suggesting only a thin liquidity cushion.
  • Total liabilities in Q3 2025 were about 1.505 billion with total equity around 0.536 billion, implying a leverage profile above 2x (liabilities to equity) and indicating a higher financial risk level.
  • Q4 2025: Net income attributable to common shareholders was -52,500,000, reflecting a substantial quarterly loss.
  • Q4 2025: Total operating income was -37,200,000, driven by elevated operating costs and restructuring charges.
  • Q4 2025: Restructuring charge of 55,899,999.5 increased costs and contributed to the quarterly loss, signaling significant one-time repositioning costs.
05/14/26 06:47 PM ETAI Generated. May Contain Errors.

Hyster-Yale Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyster-Yale's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Hyster-Yale's net income appears to be on a downward trend, with a most recent value of -$58 million in 2025, falling from $75.10 million in 2015. The previous period was $144.20 million in 2024. See where experts think Hyster-Yale is headed by visiting Hyster-Yale's forecast page.

Hyster-Yale's total operating income in 2025 was -$22.10 million, based on the following breakdown:
  • Total Gross Profit: $632.80 million
  • Total Operating Expenses: $696.40 million

Over the last 10 years, Hyster-Yale's total revenue changed from $2.58 billion in 2015 to $3.77 billion in 2025, a change of 46.2%.

Hyster-Yale's total liabilities were at $1.53 billion at the end of 2025, a 0.4% decrease from 2024, and a 141.3% increase since 2015.

In the past 10 years, Hyster-Yale's cash and equivalents has ranged from $0.00 in 2021 to $220.10 million in 2017, and is currently $123.20 million as of their latest financial filing in 2025.

Over the last 10 years, Hyster-Yale's book value per share changed from 28.22 in 2015 to 26.62 in 2025, a change of -5.7%.


Related Companies

Financial statements for NYSE:HY last updated on 4/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Needle-free peptide delivery and a $294 billion market ahead
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
What Expenses Can Be Deducted From Capital Gains Tax This Year?
Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...
SmartAsset | Sponsoredtc pixel
Distracted Americans set to miss out on quadrillions
Technology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...
Brownstone Research | Sponsoredtc pixel
Musk's acquisition pattern points to ONE stock
Musk needed solar - he acquired SolarCity. Needed data - he bought Twitter. The pattern is clear: when a suppl...
Behind the Markets | Sponsoredtc pixel